Unknown statusObservationalLast updated Jan 2, 2019

Renal Anemia Refractory to Erythropoietin

Overview

ClinicalTrials.gov ID: NCT03480178
Lead Sponsor: Assiut UniversityOTHER
Brief Summary: This study evaluates the renal anemia refractory to Epo . in hemodialysis patients. all of participants will receive Epo. and identify various factors contributing to etiology of renal anemia in Epo- resistant patients.
Study Type: Observational

Status

Overall Status: Unknown status
Start Date: Jan 2019Estimated
Primary Completion Date: Jan 2019Estimated
Completion Date: May 2019Estimated

Study Record Dates

First Submitted: Feb 13, 2018
First Submitted that Met QC Criteria: Mar 20, 2018
First Posted: Mar 29, 2018Actual
Last Update Submitted that Met QC Criteria: Dec 31, 2018
Last Update Posted: Jan 2, 2019Actual
Last Verified: Dec 2018

NCT06983756Not yet recruiting

" Evaluation of Erythropoietin Therapy in Patients With End-Stage Kidney Disease on Regular Hemodialysis: Hemoglobin Outcomes, and Metabolic Syndrome as a Risk Factor for Erythropoietin Resistance "

NCT02136563Completed

Renal Prognosis in Chronic Kidney Disease Patients With Hyporesponsive Anemia to Erythropoiesis Stimulating Agents

NCT05699109Completed

Erythropoiesis Stimulating Agents for Anemia Management in Egyptian Hemodialysis Patients

NCT03658876Completed

Predictors of Response to Iron and Erythropoietin Stimulating Agents

NCT06053866Unknown status

Prevalence of Erythropoiesis Stimulating Agents Hyporesponsiveness in Dialysis Patients in Assiut University Hospital

NCT00319150Terminated

REPEAT Study - Resistance to ErythroPoietin Effectiveness Algorithm Trial